.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

VIRACEPT Drug Profile

« Back to Dashboard
Viracept is a drug marketed by Agouron and is included in three NDAs. It is available from four suppliers.

The generic ingredient in VIRACEPT is nelfinavir mesylate. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nelfinavir mesylate profile page.

Summary for Tradename: VIRACEPT

Patents:0
Applicants:1
NDAs:3
Suppliers / Packagers: see list4

Pharmacology for Tradename: VIRACEPT

Drug ClassProtease Inhibitor
Mechanism of ActionHIV Protease Inhibitors

Clinical Trials for: VIRACEPT

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Agouron
VIRACEPT
nelfinavir mesylate
TABLET;ORAL021503-001Apr 30, 2003RXYes<disabled><disabled>
Agouron
VIRACEPT
nelfinavir mesylate
POWDER;ORAL020778-001Mar 14, 1997DISCNNo<disabled><disabled>
Agouron
VIRACEPT
nelfinavir mesylate
TABLET;ORAL020779-001Mar 14, 1997RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VIRACEPT

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Agouron
VIRACEPT
nelfinavir mesylate
POWDER;ORAL020778-001Mar 14, 19975,484,926*PED<disabled>
Agouron
VIRACEPT
nelfinavir mesylate
TABLET;ORAL021503-001Apr 30, 20035,484,926*PED<disabled>
Agouron
VIRACEPT
nelfinavir mesylate
TABLET;ORAL020779-001Mar 14, 19975,484,926*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc